Revvity, Inc. RVTY recently collaborated with Element Biosciences, Inc. The tie-up is aimed at introducing workflow solutions that can save the time and effort needed for the genomic analysis of ...

Dublin, Oct. 17, 2023 (GLOBE NEWSWIRE) -- In a groundbreaking collaboration, Revvity, Inc. and Element Biosciences, Inc. have unveiled a game-changing solution that promises to revolutionize genomic ...

Next-generation sequencing (NGS) has transformed biomedical research, offering unprecedented insights into diseases ranging from cancer to rare genetic disorders. The rapid sequencing of tumors and ...

A new research paper was published in Oncotarget's Volume 14 on May 12, 2023, entitled, "Development and implementation of an automated and highly accurate reporting process for NGS-based clonality ...

Automated library preparation is critical for reducing errors, increasing repeatability, and reducing hands-on time, allowing researchers to generate sequence data from DNA more quickly. The CyBio ...

Magnis BR outperforms existing NGS automation solutions in throughput scalability and level of automation in the testing process. This instrument is expected to bring high-quality, standardized ...

DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Next-Generation Sequencing (NGS) Process Report - Market Trends, Unmet Needs & Challenges, and Ecosystem Analysis" ...